Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christina Valbirk Konrad"'
Autor:
Wee S. Teo, Holly Holliday, Nitheesh Karthikeyan, Aurélie S. Cazet, Daniel L. Roden, Kate Harvey, Christina Valbirk Konrad, Reshma Murali, Binitha Anu Varghese, Archana P. Thankamony, Chia-Ling Chan, Andrea McFarland, Simon Junankar, Sunny Ye, Jessica Yang, Iva Nikolic, Jaynish S. Shah, Laura A. Baker, Ewan K. A. Millar, Matthew J. Naylor, Christopher J. Ormandy, Sunil R. Lakhani, Warren Kaplan, Albert S. Mellick, Sandra A. O'Toole, Alexander Swarbrick, Radhika Nair
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Breast cancers display phenotypic and functional heterogeneity and several lines of evidence support the existence of cancer stem cells (CSCs) in certain breast cancers, a minor population of cells capable of tumor initiation and metastatic dissemina
Externí odkaz:
https://doaj.org/article/2535bb7b93e94bffa1b48aa93c0aa118
Autor:
Archana P. Thankamony, Reshma Murali, Nitheesh Karthikeyan, Binitha Anu Varghese, Wee S. Teo, Andrea McFarland, Daniel L. Roden, Holly Holliday, Christina Valbirk Konrad, Aurelie Cazet, Eoin Dodson, Jessica Yang, Laura A. Baker, Jason T. George, Herbert Levine, Mohit Kumar Jolly, Alexander Swarbrick, Radhika Nair
Publikováno v:
Biomolecules, Vol 10, Iss 9, p 1295 (2020)
The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (Id1) and inhibitor of differentiation 3 (Id3) (referred to as Id) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-negativ
Externí odkaz:
https://doaj.org/article/d9b0ea32098e41d5a92df2cea25c5fd7
Autor:
Christina Valbirk Konrad, Emma Falling Iversen, Jesper Damsgaard Gunst, Ida Monrad, Andreas Holleufer, Rune Hartmann, Lars Jørgen Østergaard, Ole S. Søgaard, Mariane Høgsbjerg Schleimann, Martin Tolstrup
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e0270a2139996724756b3b2ac53e0e6
https://doi.org/10.2139/ssrn.4232082
https://doi.org/10.2139/ssrn.4232082
Publikováno v:
Konrad, C V, Murali, R, Varghese, B A & Nair, R 2017, ' The role of cancer stem cells in tumor heterogeneity and resistance to therapy ', Canadian Journal of Physiology and Pharmacology, vol. 95, no. 1, pp. 1-15 . https://doi.org/10.1139/cjpp-2016-0079
Cancer is a heterogenous disease displaying marked inter- and intra-tumoral diversity. The existence of cancer stem cells (CSCs) has been experimentally demonstrated in a number of cancer types as a subpopulation of tumor cells that drives the tumori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de207f40ff1d23f09e14d5e7c7f1881
https://doi.org/10.1139/cjpp-2016-0079
https://doi.org/10.1139/cjpp-2016-0079
Autor:
Jason T. George, Wee Siang Teo, Aurélie Cazet, Alexander Swarbrick, Andrea McFarland, Daniel L. Roden, Christina Valbirk Konrad, Eoin Dodson, P T Archana, Radhika Nair, Reshma Murali, Mohit Kumar Jolly, Herbert Levine, Binitha Anu Varghese, Nitheesh Karthikeyan, Holly Holliday
Evidence points to breast cancer following a hierarchical model, with Cancer Stem Cells (CSCs) driving critical phenotypes of the bulk tumor. Chemoresistant CSCs are not an abstract concept but have clinical consequences as they drive relapse and ult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518c5156b41d147f34d150a339377730
https://doi.org/10.1101/760686
https://doi.org/10.1101/760686
Autor:
Iva Nikolic, Sunil R. Lakhani, Alexander Swarbrick, Jessica Yang, Nitheesh Karthikeyan, Christopher J. Ormandy, Binitha Anu Varghese, Holly Holliday, Andrea McFarland, Chia-Ling Chan, Warren Kaplan, P T Archana, Sunny Ye, Simon Junankar, Mathew J. Naylor, Christina Valbirk Konrad, Daniel L. Roden, Laura A. Baker, Albert S. Mellick, Jaynish S. Shah, Sandra A O'Toole, Wee Siang Teo, Ewan K.A. Millar, Reshma Murali, Aurélie Cazet, Kate Harvey, Radhika Nair
Background Breast cancers display phenotypic and functional heterogeneity. Several lines of evidence support the existence of cancer stem cells (CSCs) in certain breast cancers, a minor population of cells capable of tumor initiation and metastatic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d605abe7ee9f1a62105742b15e0b54c3
Autor:
Alexander Swarbrick, Jessica Yang, Binitha Anu Varghese, Mohit Kumar Jolly, Herbert Levine, Wee Siang Teo, Reshma Murali, Christina Valbirk Konrad, Radhika Nair, Archana P. Thankamony, Nitheesh Karthikeyan, Holly Holliday, Daniel L. Roden, Eoin Dodson, Aurélie Cazet, Laura A. Baker, Andrea McFarland, Jason T. George
Publikováno v:
Biomolecules
Volume 10
Issue 9
Biomolecules, Vol 10, Iss 1295, p 1295 (2020)
Volume 10
Issue 9
Biomolecules, Vol 10, Iss 1295, p 1295 (2020)
The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (Id1) and inhibitor of differentiation 3 (Id3) (referred to as Id) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd8bc6c14324a824d1c3856532ace34
https://doi.org/10.3390/biom10091295
https://doi.org/10.3390/biom10091295
Publikováno v:
Aarhus University
Konrad, C V, Vibholm, L K & Schleimann, M H 2020, ' Behandling af HIV-inficerede patienter med TLR9-immunterapi inducerer HIV-specifikt immunrespons ', BestPractice Nordic, nr. Infektionsmedicin . < https://bpno.dk/2020/09/16/behandling-af-hiv-inficerede-patienter-med-tlr9-immunterapi-inducerer-hiv-specifikt-immunrespons/ >
Konrad, C V, Vibholm, L K & Schleimann, M H 2020, ' Behandling af HIV-inficerede patienter med TLR9-immunterapi inducerer HIV-specifikt immunrespons ', BestPractice Nordic, nr. Infektionsmedicin . < https://bpno.dk/2020/09/16/behandling-af-hiv-inficerede-patienter-med-tlr9-immunterapi-inducerer-hiv-specifikt-immunrespons/ >
De senere år har bragt store fremskridt i HIV-behandlingen, men HIV er fortsat en global udfordring. Behandling med TLR9-agonisten, MGN1703, kan dog – kombineret med andre interventioner med formålet at øge immun-effektor funktionen – blive et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d898cacf00f101a900b4ccb112da7601
https://pure.au.dk/portal/en/publications/behandling-af-hivinficerede-patienter-med-tlr9immunterapi-inducerer-hivspecifikt-immunrespons(2c74b1ae-e1e0-4f20-a030-4cd36c968182).html
https://pure.au.dk/portal/en/publications/behandling-af-hivinficerede-patienter-med-tlr9immunterapi-inducerer-hivspecifikt-immunrespons(2c74b1ae-e1e0-4f20-a030-4cd36c968182).html
Autor:
Andersen, Anna Halling Folkmar1,2 (AUTHOR) ahfa@clin.au.dk, Nielsen, Stine Sofie Frank1,2 (AUTHOR), Olesen, Rikke1,2 (AUTHOR), Harslund, Jakob Le Fèvre3 (AUTHOR), Søgaard, Ole Schmeltz2 (AUTHOR), Østergaard, Lars2 (AUTHOR), Denton, Paul W.4 (AUTHOR), Tolstrup, Martin1,2 (AUTHOR)
Publikováno v:
PLoS ONE. 10/29/2020, Vol. 15 Issue 10, p1-15. 15p.
Publikováno v:
Canadian Journal of Physiology & Pharmacology. 2017, Vol. 95 Issue 1, p1-15. 15p.